You are about to leave jnjmedicaldevices.com. By clicking to continue, you will be taken to a web site governed by their own Legal and Privacy Policies.
Infection Risk Management
Provides evidence-based practices aimed to address risk factors for bloodstream infections (BSIs) and surgical site infections (SSIs) through the appropriate use of JJMDC devices, including patient resources to facilitate optimal wound healing post-surgery.
Target Infection. Focus on Prevention.
50% of SSIs and BSIs account for more than half of the total annual costs associated with the most common HAIs1*
Due to pay-for-performance programs under the ACA†, infections put over 6% of a facility’s inpatient Medicare reimbursement at risk2,3
The Joint Commission's National Patient Safety Goals 07.04.01 and 07.05.01 assess a facility's evidence-based policies and practices aimed at reducing the risk of BSIs and SSIs4
- Clinical experts conduct confidential analyses of current clinical practices to help identify potential risks for SSIs and BSIs in your facility
- Customized plans to help healthcare providers implement evidence-based infection prevention strategies utilizing JJMDC devices and drive compliance with facility policies
- Educational resources designed to engage patients in their care from pre-admission through discharge
- Address risk factors for costly infections through the appropriate utilization of JJMDC devices
- Reduce variation in clinical practices and purchasing patterns
- Enhance engagement of patients and staff throughout an episode of care
- Your team shares your infection risk management goals with the Johnson & Johnson Medical Devices Companies (JJMDC)
- Together, your team and JJMDC define areas to assess for potential gaps in infection prevention practices that can be addressed by the appropriate utilization of JJMDC devices
- JJMDC clinical nurse specialist conducts a confidential, on-site analysis of current practices in your facility
- Based on assessment findings, JJMDC provides tailored recommendations to address infection risks
- Your team and JJMDC agree on training and education plans to address top needs, and establish metrics to track progress
After 6-months, the IDN achieved its goals to standardize practices across facilities, implement evidence-based infection control practices, and identify potential risks for infection.
The IDN collected data on SSI rates for a period of 10 months.
These are examples only and do not guarantee or predict future results, which will vary depending on individual circumstances.
Reduction in SSI rates for hip, knee, colon, and hysterectomy surgeries at the participating facilities (over 10 months)6
Line item fill rate (LIFR)5
Clinicians educated on evidence-based infection prevention protocols6
See How We’ve Helped
The CareAdvantage approach tailors our capabilities to customers in a variety of settings to produce concrete results.
*HAIs = Healthcare-associated infections
† ACA = Affordable Care Act
1. Zimlichman E, Henderson D, Tamir O, et al. Health care-associated infections: a meta-analysis of costs and financial impact of the US health care system. JAMA Intern Med. 013;173:2039-2046.
2. Centers for Medicare and Medicaid Services. Press release: CMS issues proposed hospital inpatient payment regulation. www.cms.gov. Accessed August 15, 2014.
3. Frequently asked questions about hospital value-based purchasing program [press release]. Centers for Medicare & Medicaid Services; April 30, 2014.
4. The Joint Commission. 2014 national patient safety goals effective January 1, 2014. Chicago, IL: The Joint Commission; 2013.
5. Spencer M, Christie J, Tyrrell P, Smirz L. 2016: A Wound Prevalence Observational Study for the Prevention of Surgical Site Infections. Poster presented at: AORN Surgical Conference & Expo; April 2-6, 2016; Anaheim, CA.
6. Ethicon US, LLC. Evidence-Based Surgical Bundle Training Attendance Record. December 2015.